Top Tweets for #LS022

3 days ago

🚨 Results from #LITESPARK022 (#LS022) are out in @NEJM! 1/This phase III trial evaluated whether adding the HIF-2α inhibitor Belzutifan (BEL) to adjuvant pembrolizumab (PEMBRO) could improve outcomes for patients with resected clear-cell RCC at increased risk for recurrence. https://t.co/1BLAercj3p @oncoalert @asco @myESMO

DrChoueiri's tweet photo. 🚨 Results from #LITESPARK022 (#LS022) are out in @NEJM!

1/This phase III trial evaluated whether adding the HIF-2α inhibitor Belzutifan (BEL) to adjuvant pembrolizumab (PEMBRO) could improve outcomes for patients with resected clear-cell RCC at increased risk for recurrence.

https://t.co/1BLAercj3p
@oncoalert @asco @myESMO

193

21K

RenditeFux

@RenditeFux

over 7 years ago

Hey! - #Raphael Oldfox hat gerade ein neues #YouTube Video #hochgebeamt. ;D „☠️😄 Wochenendström - #LS022 - #FREIAB18 // News, Talk & Relax“ - https://t.co/IR5PFQgAxg

Top Tweets for #LS022

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users